{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:52:53Z","timestamp":1777715573904,"version":"3.51.4"},"reference-count":13,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Psychiatry Med"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to assess factors associated with SARS-CoV-2 (COVID-19) vaccination in patients in 2 inpatient forensic psychiatric hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective chart review evaluating factors associated with COVID-19 vaccination for patients residing in two inpatient forensic psychiatric hospitals between January 1, 2021 and February 28, 2022. Data was collected through electronic medical records utilizing MetaCare Enterprise\u2122 and secure facility computer drives, individual patient paper charts, and Missouri\u2019s vaccination records database, ShowMeVax. Several variables were collected to assess factors associated with COVID-19 vaccination. Additionally, COVID-19 vaccination rates were compared to the influenza vaccination rates at these hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 229 patients (84.5%) were vaccinated against COVID-19 during or before the study period and 42 (15.5%) were unvaccinated. Patients who were deemed incompetent to stand trial were less likely to receive the COVID-19 vaccine. Those that had a higher body mass index (BMI), were diagnosed with multiple comorbid conditions, not prescribed involuntary medications, were offered incentives, and received the influenza vaccine were more likely to receive the COVID-19 vaccine. Education level, race, sex, age, and being prescribed psychiatric medications did not affect vaccination status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patient specific factors should be used when educating and offering COVID-19 vaccines to patients in an inpatient forensic psychiatric unit. Awareness of these results can facilitate targeted interventions for optimal care in a psychiatric population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00912174221144128","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T21:56:01Z","timestamp":1670277361000},"page":"160-171","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with COVID-19 vaccination for patients in an inpatient forensic psychiatric hospital"],"prefix":"10.1177","volume":"58","author":[{"given":"Lauren N.","family":"McCulley","sequence":"first","affiliation":[{"name":"Center for Behavioral Medicine, Kansas City, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4511-1735","authenticated-orcid":false,"given":"Shelby E.","family":"Lang","sequence":"additional","affiliation":[{"name":"Center for Behavioral Medicine, Kansas City, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie R.","family":"Kriz","sequence":"additional","affiliation":[{"name":"University of Missouri-Kansas City School of Pharmacy, Kansas City, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney A.","family":"Iuppa","sequence":"additional","affiliation":[{"name":"Center for Behavioral Medicine, Kansas City, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh Anne","family":"Nelson","sequence":"additional","affiliation":[{"name":"University of Missouri-Kansas City School of Pharmacy, Kansas City, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole A.","family":"Gramlich","sequence":"additional","affiliation":[{"name":"Northwest Missouri Psychiatric Rehabilitation Center, St. Joseph, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellie S. R.","family":"Elliott","sequence":"additional","affiliation":[{"name":"Center for Behavioral Medicine, Kansas City, MO, USA"},{"name":"Northwest Missouri Psychiatric Rehabilitation Center, St. Joseph, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger W.","family":"Sommi","sequence":"additional","affiliation":[{"name":"University of Missouri-Kansas City School of Pharmacy, Kansas City, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"bibr1-00912174221144128","unstructured":"Office of the Commissioner. FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine. FDA. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19. Published December 11, 2020. Accessed September 1, 2021."},{"key":"bibr2-00912174221144128","unstructured":"Office of the Commissioner. FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine. FDA. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid. Published December 18, 2020. Accessed September 1, 2021."},{"key":"bibr3-00912174221144128","unstructured":"COVID CDC. Data tracker. centers for disease control and prevention. https:\/\/covid.cdc.gov\/covid-data-tracker. Published March 28, 2020. Accessed April 12, 2022."},{"key":"bibr4-00912174221144128","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00301-1"},{"key":"bibr5-00912174221144128","volume-title":"COVID-19 and Your Health","author":"CDC"},{"key":"bibr6-00912174221144128","unstructured":"Houtven CHV, Boucher NA, Dawson WD. Impact of the COVID-19 outbreak on long-term care in the united states. Resources to support community and institutional long-term care responses to COVID-19. Published April 24, 2020. Accessed September 1, 2021. https:\/\/ltccovid.org\/2020\/04\/24\/impact-of-the-covid-19-outbreak-on-long-term-care-in-the-united-states\/"},{"key":"bibr7-00912174221144128","unstructured":"Dooling K, Marin M, Wallace M, et al. The advisory committee on immunization practices\u2019 updated interim recommendation for allocation of COVID-19 vaccine-United States, December 2020. Published January 1, 2021. Accessed August 15, 2022."},{"key":"bibr8-00912174221144128","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20806"},{"key":"bibr9-00912174221144128","unstructured":"Roesch R, Zapf R, Golding S, Skeem J. Defining and assessing competency to stand trial. The United States Department of Justice. https:\/\/www.justice.gov\/sites\/default\/files\/eoir\/legacy\/2014\/08\/15\/Defining_and_Assessing_Competency_to_Stand_Trial.pdf. Accessed June 10, 2022."},{"key":"bibr10-00912174221144128","unstructured":"Department Operating Regulation 4.152 Administration of Psychotropic Medications Involuntarily. Department operating regulation 4.152 administration of psychotropic medications involuntarily|dmh.mo.gov. https:\/\/dmh.mo.gov\/media\/pdf\/department-operating-regulation-4152-administration-psychotropic-medications. Accessed June 10, 2022."},{"key":"bibr11-00912174221144128","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.4.489"},{"key":"bibr12-00912174221144128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"bibr13-00912174221144128","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100205"}],"container-title":["The International Journal of Psychiatry in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00912174221144128","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00912174221144128","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00912174221144128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:15:33Z","timestamp":1777457733000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00912174221144128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1177\/00912174221144128"],"URL":"https:\/\/doi.org\/10.1177\/00912174221144128","relation":{},"ISSN":["0091-2174","1541-3527"],"issn-type":[{"value":"0091-2174","type":"print"},{"value":"1541-3527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]}}}